Drosha inclusions are new components of dipeptide-repeat protein aggregates in FTLD-TDP and ALS C9orf72 expansion cases

Journal of Neuropathology and Experimental Neurology
Sílvia PortaVirginia M Y Lee

Abstract

Frontotemporal lobar degeneration (FTLD) and amyotrophic lateral sclerosis (ALS) are 2 neurodegenerative disorders that share clinical, genetic, and neuropathologic features. The presence of abnormal expansions of GGGGCC repeats (G4C2 repeats) in a noncoding region of the Chromosome 9 open reading frame 72 (C9orf72) gene is the major genetic cause of both FTLD and ALS. Transcribed G4C2 repeats can form nuclear RNA foci and recruit RNA-binding proteins, thereby inhibiting their normal function. Moreover, through a repeat-associated non-ATG translation mechanism, G4C2 repeats translation leads to dipeptide-repeat protein aggregation in the cytoplasm of neurons. Here, we identify Drosha protein as a new component of these dipeptide-repeat aggregates. In C9orf72 mutation cases of FTLD-TDP (c9FTLD-TDP) and ALS (c9ALS), but not in FTLD or ALS cases without C9orf72 mutation, Drosha is mislocalized to form neuronal cytoplasmic inclusions in the hippocampus, frontal cortex, and cerebellum. Further characterization of Drosha-positive neuronal cytoplasmic inclusions in the hippocampus, frontal cortex, and cerebellum revealed colocalization with p62 and ubiquilin-2, 2 pathognomonic signatures of c9FTLD-TDP and c9ALS cases; however, Drosha ...Continue Reading

References

Sep 23, 2003·Clinical Chemistry·Vivianna M Van DeerlinVirginia M-Y Lee
Nov 25, 2003·Science·Elsebet LundUlrike Kutay
Dec 19, 2003·Genes & Development·Rui YiBryan R Cullen
Sep 10, 2004·Nucleic Acids Research·Yan Zeng, Bryan R Cullen
Nov 9, 2004·Nature·Richard I GregoryRamin Shiekhattar
Nov 9, 2004·Nature·Ahmet M DenliGregory J Hannon
Dec 3, 2004·Genes & Development·Jinju HanV Narry Kim
Oct 19, 2006·Journal of Biomedicine & Biotechnology·Marie W WootenMichael C Wooten
Sep 1, 2007·Science·Jongpil KimAsa Abeliovich
Apr 25, 2008·Proceedings of the National Academy of Sciences of the United States of America·Sébastien S HébertBart De Strooper
Jul 23, 2009·Neuropathology : Official Journal of the Japanese Society of Neuropathology·Maria PikkarainenIrina Alafuzoff
Sep 25, 2010·Lancet Neurology·Ian Ra MackenzieManuela Neumann
Dec 15, 2010·Neuron·Janel O JohnsonBryan J Traynor
Jan 13, 2011·Current Alzheimer Research·R FerrariP Momeni
Jun 7, 2011·Acta Neuropathologica·Ian R A MackenzieVirginia M Y Lee
Feb 4, 2012·Brain : a Journal of Neurology·Julie S SnowdenStuart M Pickering-Brown
Feb 4, 2012·Brain : a Journal of Neurology·Javier Simón-SánchezJohn C van Swieten
Feb 11, 2012·Proceedings of the National Academy of Sciences of the United States of America·Yukio Kawahara, Ai Mieda-Sato
Mar 1, 2012·Brain : a Journal of Neurology·Johnathan Cooper-KnockPamela J Shaw
Mar 20, 2012·Acta Neuropathologica·Johannes BrettschneiderJohn Q Trojanowski
Apr 6, 2012·Current Neurology and Neuroscience Reports·Huw R MorrisDerek J Blake
May 29, 2012·RNA·Jillian S ShapiroBenjamin R Tenoever
Oct 2, 2012·Nature Neuroscience·Clotilde Lagier-TourenneGene W Yeo
Nov 1, 2012·Human Mutation·Julie van der ZeeUNKNOWN European Early-Onset Dementia Consortium

❮ Previous
Next ❯

Citations

Jan 19, 2016·Brain Research·Chen Eitan, Eran Hornstein
Aug 25, 2015·Brain : a Journal of Neurology·Allan McCarthyTim Lynch
Jun 9, 2016·Acta Neuropathologica·Steven BoeynaemsLudo Van Den Bosch
Apr 23, 2016·Journal of Alzheimer's Disease : JAD·Shan-Shan TangJin-Tai Yu
Jun 3, 2017·Nucleic Acids Research·Helen J CurtisMiguel A Varela
Jan 13, 2018·Frontiers in Neuroscience·Vijay KumarMd Imtaiyaz Hassan
Oct 29, 2018·Acta Neuropathologica·Sarat C VatsavayaiWilliam W Seeley
Feb 7, 2019·Frontiers in Genetics·Zoe Butti, Shunmoogum A Patten
Dec 13, 2016·Cellular and Molecular Neurobiology·Bor Luen Tang
Jun 6, 2019·Frontiers in Molecular Neuroscience·Samantha K BartonBradley J Turner
Aug 29, 2020·Journal of Personalized Medicine·Laura Le GallStephanie Duguez
Jun 3, 2018·Molecular Neurodegeneration·Tatyana A ShelkovnikovaVladimir L Buchman

❮ Previous
Next ❯

Software Mentioned

NIS
ImageJ
Elements
Leica LAS - AF

Related Concepts

Related Feeds

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating genetic alterations in this genetically heterogeneous disorder.

ALS & FTD: TDP-43

TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.